Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Romark Laboratories LcfiledCriticalRomark Laboratories Lc
Priority to HN2000000288ApriorityCriticalpatent/HN2000000288A/en
Publication of HN2000000288ApublicationCriticalpatent/HN2000000288A/en
229940088679drug related substanceDrugs0.000abstract1
Landscapes
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Abstract
SE HA OBSERVADO EN ESTUDIOS CLINICOS DESAROLLADOS CON ANIMALES Y SERES HUMANOS QUE LA EFICIENCIA DEL TRATAMIENTO CON COMPUESTOS DE LA FORMULA (I) Y (II) DEPENDE EDEL TAMAÑO DE PERTICULA DE LA SUSTANCIA DE LA DROGA ACTIVA Y DE LA ESTABILIDAD DE LOS COMPUESTOS. LAS COMPOSICIONES FARMACEUTICAS DESCRITAS SON CONVENIENTES PARA EL TRATAMIENTO DE INFECCIONES POR TREMATODOS EN SERES HUMANOS Y ANIMALES CAUSADAS POR ESQUISITOMAS COMO EL SCHISTOMA MANSONIIT HAS BEEN OBSERVED IN CLINICAL STUDIES WITH ANIMALS AND HUMANS THAT THE EFFICIENCY OF THE TREATMENT WITH COMPOUNDS OF FORMULA (I) AND (II) DEPENDS ON THE PERTICULA SIZE ON THE ACTIVE DRUG SUBSTANCE AND THE STABILITY OF THE COMPOUNDS. THE DESCRIBED PHARMACEUTICAL COMPOSITIONS ARE SUITABLE FOR THE TREATMENT OF TREMATODE INFECTIONS IN HUMANS AND ANIMALS CAUSED BY SCHISITOMAS SUCH AS SCHISTOMA MANSONI
HN2000000288A2000-12-222000-12-22
PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDA AND NITAZOXANIDA
HN2000000288A
(en)
"PIRROLO DERIVATIVES (3,4-C) PIRAZOL ACTIVE AS QUINASE INHIBITORS, PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM."
DERIVATIVES OF NITROSODIFENILAMINE AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM AS MEDICINES THAT CAN BE USED IN THE TREATMENT OF PATHOLOGIES CHARACTERIZED BY OXIDATIVE STRESS